As House Democrats launch a formal impeachment inquiry against President Trump, bipartisan healthcare efforts focused on lowering drug prices and healthcare costs are at risk of falling by the wayside, The Hill reported.
The impeachment process could put a halt to some of the bipartisan talks between Republicans and Democrats, particularly surrounding surprise billing and high drug prices, where some common ground has been found.
House Speaker Nancy Pelosi (D-CA) recently introduced a bill aimed at lowering drug prices, while the Trump administration has taken several steps to lower drug prices or reform healthcare prices by mandating more transparency. However, healthcare may not be the only critical legislative issue placed on the backburner, according to The Hill.
With an impeachment inquiry marching ahead, Democrats are still working on healthcare proposals––for now. Pelosi’s bill was reviewed by the House Energy and Commerce Committee Sept. 25, The Hill noted. During previous impeachment inquiries in other administrations, agendas still moved forward.
See the full story below: